In vitro Cytotoxicity of Silver Nanoparticles on Human Periodontal Fibroblasts

Silver nanoparticles (NNPs) are extensively used for all kinds of antimicrobial applications in medical research. Their efficacy has been demonstrated against Streptococcus mutans, which is associated with dental caries. However, their cytotoxic effects on human periodontal tissue are not completely understood.Objective: The aim of this study was to evaluate the possible toxic cellular effects of different concentrations and sizes of silver nanoparticles, less than 10 nm, 15–20 nm, and 80–100 nm, respectively, on human periodontal fibroblasts. Study design: Primary culture cells isolated from human periodontal tissue were exposed to 0–1,000 µM silver nanoparticles of each size for 24-, 72-, and 168-hour periods. Cytotoxicity was evaluated with a nonradioactive, soluble MTS/PMS assay. Results: The results demonstrated that silver nanoparticles of less than 20 nm increased cytotoxicity in human periodontal fibroblasts in a dose- and time-dependent manner. Conclusion: The 80–100-nm-sized nanoparticles did not modify the viability of human primary culture cells.

nanoparticles, silver, cytotoxicity, fibroblast

1. Furno F, Morley KS, Wong B, et al. Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection? J Antimi-crob Chemother, 54: 1009–1024, 2004.

2. Cheng D, Yang J, Zhao Y. Antibacterial materials of silver nanoparti-cles  application  in  medical  appliances  and  appliances  for  daily  use. Chin Med Equip J 4:26–32, 2004.

3. Osborne JW. Amalgam: dead or alive? Dent Update, 33: 94–98, 2006.

4. Gomes  DR,  Vasconcellos  RM,  Rastelli  MC,  Czlusniak  GD,  Stadler WD. Diamino fluoreto de prata: uma revisão de literatura. UEPG Ci Biol Saúde, Ponta Grossa, 12: 45–52, 2006.

5. Llodra JC, Rodriguez A, Ferrer B, Menardia V, Ramos T, Morato M. Efficacy of silver diamine fluoride for caries reduction in primary teeth and first permanent molars of schoolchildren: 36 month clinical trial. J Dent Res, 84: 21–24, 2005.

6. Elechiguerra  JL,  Burt  JL,  Morones  JR,  et  al.  Interaction  of  silver nanoparticles with HIV-1. J Nanobiotechnology, 3: 1–10, 2005.

7. Hernández-Sierra JF, Ruiz F, Pena DC, et al. The antimicrobial sensi-tivity  of  Streptococcus mutans to  nanoparticles  of  silver,  zinc  oxide, and gold. Nanomedicine, 4: 237–240, 2008. 

8. Van de Voorde K, Nijsten T, Schelfhout K, Moorkens G, Lambert J. Long-term  use  of  silver  containing  nose-drops  resulting  in  systemic argyria. Acta Clin Belg, 60: 33–35, 2005.

9. Eturska M, Obreshkova E. Argyria in the prolonged use of adsorgan. Vutr Boles, 18: 121–123, 1979.

10. Spencer WH, Garron LK, Contreras F, Hayes TL, Lai C. Endogenous and exogenous ocular and systemic silver deposition. Trans Ophthal-mol Soc UK, 100: 171–178, 1980.

11. Lansdown AB. Silver in health care: antimicrobial effects and safety in use. Curr Probl Dermatol, 33: 17–34, 2006.

12. Murray PE, Garcia-Godoy C, Garcia-Godoy F. How is the biocompat-ibility of dental biomaterials evaluated? Med Oral Patol Oral Cir Bucal, 12: 58–66, 2007.

13. Pischon N, Zimmermann B, Bernimoulin JP, Hägewald S. Effects of an enamel matrix derivate on human osteoblasts and PDL cells grown in organoid cultures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 102: 551–557, 2006.

14. Keiser  K,  Johnson  CC,  Tipton  DA.  Cytotoxicity  of  mineral  trioxide aggregate using human periodontal ligament fibroblasts. J Endod, 26: 288–291, 2000.

15. Pucher  JJ,  Daniel  JC.  The  effects  of  chlorhexidine  digluconate  on human fibroblasts in vitro. J Periodontol, 63: 526–532, 1992.

16. Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann MC. In vitro cyto-toxicity  of  nanoparticles  in  mammalian  germline  stem  cells. Toxicol Sci, 88: 412–419, 2005.

17. Alt  V,  Bechert  T,  Steinrücke  P,  et  al. An  in  vitro  assessment  of  the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials, 25: 4383–4391, 2004.

18. Zhang Y, Chen F, Zhuang J, et al. Synthesis of silver nanoparticles via electrochemical reduction on compact zeolite film modified electrodes. Chem Commun, 7: 2814–2815, 2002.

19. Sun Y, Xia Y. Shape-controlled synthesis of gold and silver nanoparti-cles. Science, 298: 2176–2179, 2002.

20. Bogle KA, Dhole SD, Bhoraskar VN. Silver nanoparticles: synthesis and  size  control  by  electron  irradiation.  Nanotechnology,  17: 3204–3208, 2006.

21. Cecere  D,  Bruno A,  Minutolo  P,  D’Alessio A.  DLS  measurement  of nanoparticles produced in laminar premixed flames. Synthetic Metals, 139: 653–656, 2003.

22. Rose GG, Yamasaki A, Pinero GJ, Mahan CJ. Human periodontal liga-mento cells in vitro. J Periodontal Res, 22: 20–28, 1987.

23. Phipps RP, Borrello MA, Blieden TM. Fibroblast heterogeneity in the periodontium and other tissues. J Periodontal Res, 32: 159–165, 1997.

24. Ogata Y, Niisato N, Sakurai T, Furuyama S, Sugiya H. Comparison of the characteristics of human gingival fibroblasts and periodontal liga-ment cells. J Periodontol, 66: 1025–1031, 1995.

25. Giannopoulou  C,  Cimasoni  G.  Functional  characteristics  of  gingival and periodontal ligament fibroblasts. J Dent Res, 75: 895–902, 1996.

26. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 19: 975–983, 2005.

27. Fu J, Ji J, Fan D, Shen J. Construction of antibacterial multilayer films containing nanosilver via layer-by-layer assembly of heparin and chi-tosan-silver ions complex. J Biomed Mater Res A, 79: 665–674, 2006.

28. Carlson  C,  Hussain  SM,  et  al. Unique  cellular  interaction  of  silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B, 112: 13608–13619, 2008.